Breaking News

Ginkgo Bioworks Awarded $18M DARPA Contract

Ginkgo aims to deliver advances in on-demand protein manufacturing leveraging Cell-Free Protein Synthesis.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Ginkgo Bioworks, a biotech company building a platform for cell programming and biosecurity, has been awarded a four-year Defense Advanced Research Projects Agency (DARPA) contract worth up to $18 million to explore new ways to manufacture complex therapeutic proteins. For DARPA’s Reimagining Protein Manufacturing (RPM) project, Ginkgo aims to deliver advances in on-demand protein manufacturing leveraging Cell-Free Protein Synthesis (CFPS) to enable rapid, high-yield, distributed produc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters